I do believe the burns trials phase 1/2 are being funded by the WA government in conjunction with Fiona Stanley hospital at no cost to Recce other than supply of the compound.
Recce seems to be very shrewd in looking for opportunities to get others to carry the cost of research, out of the many places currently test our compounds I believe (could be wrong) the intravenous phase 1 trial at CMAX is the only one we are paying for other than in house preclinical.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-10
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $102.0M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 46.5¢ | 46.0¢ | $145.6K | 316.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 82151 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 57606 | 2 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RCE (ASX) Chart |